Mitochondrial dynamics during nutrient starvation of cancer cells likely exert profound effects on their capability for metastatic progression. Here we report that KAP1 (TRIM28), a transcriptional co-adaptor protein implicated in metastatic progression in breast cancer, is a pivotal regulator of mitochondrial fusion in glucose-starved cancer cells. Diverse metabolic stresses induced Ser473-phosphorylation of KAP1 (pS473-KAP1) in a ROS-and p38-dependent manner. Results from live cell imaging and molecular studies revealed that during the first 6-8 hr of glucose starvation mitochondria initially underwent extensive fusion, but then subsequently fragmented in a pS473-KAP1-dependent manner. Mechanistic investigations using phosphorylation-defective mutants revealed that KAP1 Ser473-phosphorylation limited mitochondrial hyperfusion in glucose-starved breast cancer cells, as driven by downregulation of the mitofusin protein MFN2, leading to reduced oxidative phosphorylation and ROS production. In clinical specimens of breast cancer, reduced expression of MFN2 corresponded to poor prognosis in patients. In a mouse xenograft model of human breast cancer, there was an association in the core region of tumors between MFN2 downregulation and the presence of highly fragmented mitochondria. Collectively, our results suggest that KAP1 Ser473 phosphorylation acts through MFN2 reduction to restrict mitochondrial hyperfusion, thereby contributing to cancer cell survival under conditions of sustained metabolic stress.
Introduction
Cancer cells require more nutrients to support their higher proliferation compared with normal cells. For example, increased glucose uptake, also known as Warburg effect, is one of the wellcharacterized tumor hallmarks (1) . During the course of tumor growth, cancer cells encounter various microenvironmental stresses from transient or fluctuating (acute) to diffusion-limited (chronic) hypoxia and nutrient starvation. In response to these stress conditions, cells activate a number of signaling pathways to survive diverse types of nutrient deprivation (2) . One of the most prominent adaptive responses is to regulate mitochondrial dynamics (3, 4) . Mitochondria undergo dynamic fusion and fission processes that affect cellular biosynthetic and bioenergetic efficiency and emerging evidence suggests that dysregulated mitochondrial dynamics are associated with human diseases, including cancers (5) . The balance between fragmented mitochondria and elongated mitochondria is governed by a family of GTP-dependent dynaminrelated 'mitochondria-shaping' proteins (6) . While the dynamic-related protein 1 (DRP1) drives mitochondrial fission, the mitofusin 1/2 (MFN1/2) and optic atrophy 1 (OPA1) proteins mediate fusion of the mitochondrial outer and inner membranes, respectively.
Based on the distance from the nearest blood vessel, tumors contain well-vascularized and poorly vascularized regions, which are thought to utilize mitochondria differently. Aerobic oxidative phosphorylation (OXPHOS) is essential for ATP production to support cell growth and is also the major intracellular source of reactive oxygen species (ROS). It has been reported that glucose deprivation induces metabolic oxidative stress via an increase in the steady-state levels of mitochondrial superoxide and hydrogen peroxide (7) (8) (9) (10) . In addition, it is also well documented that the prolonged depletion of various nutrients, such as glucose, glutamine, or arginine, induces ROS-triggered cancer cell death (11) (12) (13) (14) . Considering that mitochondrial fusion maximizes ATP generation under nutrient starvation (3, 4) and that excessive ROS production is detrimental to the cells (15) , regional regulation of mitochondrial function inside the tumors becomes essential not only for bioenergetics but also for modulating intracellular redox state.
Therefore, the ability of tumor cells to dynamically regulate the balance between mitochondrial fusion and fission is critical for their adaptation to metabolic stress caused by the temporal regional heterogeneity. However, the mechanisms underlying the transition from mitochondrial fusion to fission during the course of sustained nutrient depletion are not completely understood.
KRAB domain-associated protein 1 (KAP1/TRIM28) is a pleiotropic regulator of a diverse range of cellular process (16) . Notably, overexpressed KAP1 has emerged as an oncogene in different types of tumors, including breast cancer (17) . Previous work by us and others have shown that KAP1 is subjected to phosphorylation at multiple serine (Ser) residues, including Ser440, Ser473, Ser501 and Ser824 (16) . Among these, although ATM-mediated Ser824 phosphorylation is associated with DNA damage response (18) (19) (20) (21) (22) , the kinase responsible for and the role of KAP1 Ser473-phosphorylation (pS473-KAP1) in the context of metabolic stress is poorly understood. Here, we demonstrated that pS473-KAP1 is transiently activated following prolonged starvation by ROS-p38MAPK pathway, and pS473-KAP1 reduces mitochondrial hyperfusion, promoting colony formation in response to chronic glucose deprivation.
Mechanistically, pS473-KAP1-dependent adaptive response is characterized by a reduction of MFN2. The accumulation of fragmented mitochondria in the core region, compared to the periphery, of xenografted tumors supports the regional heterogeneity of mitochondrial dynamics.
Lastly, reduced MFN2 expression in breast cancer is associated with poor survival and metastasis corroborates the concept that suppression of MFN2-mediated mitochondrial fusion may underline the poor prognosis of breast cancer patients. Taken together, our studies suggest a paradigm by which ROS-p38MAPK-pS473-KAP1-MFN2 axis prevents mitochondrial MDA-MB-231/shKAP1/KAP1S473A/Su9-GFP and MDA-MB-231/shKAP1/KAP1S473D/COX4-DsRed cells were maintained in the presence of puromycin (2 µg/ml) and G418 (100 µg/ml).
MDA-MB-231/MFN2 cells were maintained in the presence of G418 (100 µg/ml). All nutrient depletion media were prepared with 10% dialyzed fetal bovine serum (Gibco, 26400). The glucose depletion medium was DMEM (Gibco, 11966-025) supplemented with sodium pyruvate (1 mM). The glutamine depletion medium was DMEM (Gibco, 15-013-CV). The arginine depletion medium was DMEM (Gibco, A14431-01) supplemented with L-glutamine (4 mM) and L-lysine (0.8 mM). Etomoxir (sc-215009), siRNAs against p38α (sc-29433), p38β (sc-39116) and Mfn2 (sc-43928) were from Santa Cruz biotechnology. N-acetyl-L-cysteine (A7250), Mdivi-1 (M0199), D-glucose (G7021), oligomycin A (75351), Rotenone (R8875) and FCCP (C2920) were from Sigma-Aldrich. SB203580 (152121-47-6) was from Biovision.
Plasmid and cell engineering. shRNA (TRCN0000017998) against the KAP1 3'UTR was obtained from The RNAi Consortium. MDA-MB-231/shKAP1 cells were generated using lentivirus system as described previously (12) . FLAG-S473A-KAP1 and FLAG-S473D-KAP1
were engineered using FLAG-KAP1 as a template (22) , respectively, by the Transformer Site Directed Mutagenesis Kit (Clonetech). The MFN2 donor vector (HsCD00039867) was obtained from the DNASU Plasmid Repository. All KAP1 constructs were subcloned into the pDONR201 donor vector and recombined into lentiviral-gateway-compatible destination vectors with tetracycline-responsive promoter using GATEWAY technology (Invitrogen). Lentiviruses were generated as described previously (12) . All constructs were validated by sequencing analyses.
Western blot analyses and antibodies. Western blot analysis was conducted as described previously (23) . Antibodies used were phospho-S473-KAP1 (644602, BioLegend), phospho-S824-KAP1 (A300-767A, Bethyl), KAP1 (A300-274A, Bethyl), β-actin (MAB1501R), H3K27me Cell viability, clonogenic cell survival and apoptosis assay. The acid phosphatase (ACP) assay was used to measure cell viability as described previously (12) . Briefly, 5000 cells/well in the 96-well plate were seeded and incubated with different concentrations of glucose or treated with Mdivi-1 (10 µM) for 3-days. Alternatively, clonogenic cell survival was performed 48-hr after nutrient deprivation. Cells were trypsinized, combined with suspended cells, and total 100 cells were reseeded in 6-well plate for 2-weeks as described previously (7) . Apoptosis was analyzed by Annexin V/Propidium iodide (PI) staining (BD Pharmingen) as described previously (12) .
Soft-agar colony formation. 5,000 cells were mixed in 0.35% agarose in complete medium (top layer) and were plated on 0.7% agarose with complete medium (bottom layer) in 6-well plates. Extra medium with different concentration of glucose were added to each wells and the medium were changed every 5-day during the 2-week of cell growth. Colonies were imaged as described previously (12) .
Intracellular ROS measurement. ROS measurement was performed using DCFDA (D6883, Sigma) staining as described previously (12) . ATP assay. ATP production was determined using the ENLITEN ® ATP Assay System (Promega, FF2000) according to the manufacturer's instructions. Briefly, cells were harvested in cold PBS and then added to 5% trichloroacetic acid (TCA). Subsequently, tris-acetate buffer (pH 7.75) was used to neutralize the TCA solution to a final concentration of 0.1%. The extracts were further diluted 1:100 and an equal volume of rL/L Reagent (Promega, FF2000) was added to measure the luminescence using a TD-20e luminometer (Turner). The ATP amount was normalized to cell number and the relative ATP level was calculated.
Immunofluorescence staining and imaging. Tom20 antibody (sc-17764, Santa Cruz) was used for immunofluorescence staining to visualize mitochondrial morphology as described previously (12) . Slides were viewed using a 60X objective on an inverted IX81 microscope Formalin-fixed, paraffin-embedded (FFPE) sections were subjected to immunohistochemistry (IHC) staining with MFN2 antibody (WH0009927M3, Sigma) by the pathology core at City of Hope. Tumors were dissected into core and peripheral regions and subjected to Western blotting analysis as described previously (26) . Tumors for visualizing COX4-DsRed fluorescence were fixed in paraformaldehyde (4%) at 4°C overnight, and then subjected to 15% and 30% sucrose infiltration and O.C.T embedding. Sections were sliced at 8 µm on the cryostat (CM3050S, Leica).
Patient materials and Immunohistochemistry. The institutional review board of Chi-Mei
Medical Center approved the procurement of formalin-fixed tissue and acquisition of clinical information for this study (IRB10210004). IHC staining was performed with MFN2 antibody (WH0009927M3, Sigma) as previously described (27) (Table 1) , as described previously (28) .
Bioinformatics. The Cancer Genome Atlas (TCGA) dataset, the Netherlands Cancer Institute (NKI) dataset and Prognoscan database (http://www.prognoscan.org/) were used for data mining of mitochondrial complex genes and KAP1 as well as the clinical relevance (29-32).
Histograms were generated by software R or GraphPad Prism 6. Heatmap was generated by significance was determined using the two-tailed Student's t-test. Chi-square test was used to evaluate the correlations between MFN2 expression and various clinicopathological features.
Survival analyses were performed for disease-specific and distal metastasis-free survivals.
Survival curves were plotted using the Kaplan-Meier method. Figure 1D , lower panel) all increased pS473-KAP1. Together, we proposed that pS473-KAP1
Results

KAP1
represents a common response to diverse nutrient starvation in breast cancer cells.
To identify the pathway for pS473-KAP1 induction, we first found that the AMPK inhibitor, compound C did not alter the glutamine starvation-induced pS473-KAP1 (Supplementary Figure   S3A , upper panel). In parallel, pS473-KAP1 persisted in glutamine-deprived AMPKα1/AMPKα2 double knockout mouse embryonic fibroblasts (MEFs) (Supplementary Figure S3A, lower panel) .
Similarly, we used the ATM inhibitor, Ku55933, and knockdown of CHK2 and PKCδ by small interfering (si) RNA to exclude the involvement of ATM-CHK2 (33) and PKCδ (34) pathways in inducing pS473-KAP1 under starvation (Supplementary Figures S3B, C) .
Based on previous observations that metabolic stress induces ROS production in cells To assess whether unbalanced mitochondrial fusion sensitizes cells toward glucose depletion-induced cell death, we assessed cell viability of glucose-starved MDA-MB-231 cells with (or not) Mdivi-1. Figure 2D showed that both glucose deprivation and Mdivi-1 pre-treatment increased mitochondrial maximal respiration. Moreover, Mdivi-1 pre-treatment further increased ROS signal ( Figure 2E ) and sensitized cells to glucose starvation-induced cell death (Supplementary Figure S5D) . Likewise, expression of S473A-KAP1, but not wt-and S473D-KAP1, significantly decreased the viability of glucose-starved cells ( Figure 2F ). Together, these results supported a positive correlation between mitochondrial hyperfusion and elevated OCR.
Notably, elevated maximal respiration could account for increased ROS generation. Figure 3D ). We also observed higher basal ROS in the S473A-KAP1 expressing cells in the presence or absence of glucose ( Figure 3E) . Lastly, the correlation between MFN2 and ROS level was established using wild type and mfn2 knockout MEFs ( Figure 3F ). We next addressed whether different MFN2 level affects nutrient sensitivity in MDA-MB-231 cells. As shown in Figure 3G , MFN2 over-expression and knockdown have opposite effect on nutrient sensitivity.
Together with the observations on the mitochondrial hyperfusion upon arginine starvation in MDA-MB-231 cells (Supplementary Figures S5E, F) , we proposed that mitochondrial hyperfusion aggravated the response to nutrient deprivation. Analyses of the RNA-seq data further uncovered additional roles for S473D-KAP1 in elevating the expression of mitochondrial complex genes ( Figure 3H ). reflecting reduced lysine demethylases (KDMs) activity due to a decrease in their cofactor, α-ketoglutarate level, attested to the regional metabolic stress inside tumors. Lastly, we sought to explore the biological consequence of metabolic stress-induced pS473-KAP1. Figure 4D revealed that S473A-KAP1-expressing cells were more sensitive to glucose reduction using an anchorage-independent cell growth assay.
Association of MFN2 expression and mitochondrial network in vivo.
To assess the pathological relevance of MFN2 level in breast cancer, we found that the loss-of-MFN2 expression was associated with adverse clinicopathological features and worse patient outcome (Table 1) . Notably, MFN2 low expression was significantly associated with increments of primary tumor status (p=0.001), nodal metastasis (p=0.033), and stage (p=0.002) ( Figure 5A ). Multivariate analysis showed that loss-of-MFN2 expression, along with higher stage, remained to be prognostically significant for disease-specific (p=0.0024) and metastasis-free (p<0.0001) survival ( Figure 5B) . Consistently, the TCGA breast cancer dataset showed that MFN2 message was lower in breast tumors compared to normal tissues ( Figures   5C ). Data mining on PrognoScan database (http://www.prognoscan.org/) (29) showed that reduced MFN2 message was correlated with poor survivals (Figures 5D -G) . Altogether, our results highlighted the importance of p38/pS473-KAP1/MFN2 pathway in promoting tumor cells' survival under metabolic stress.
Discussion
Cancer cells are usually in a state of chronic oxidative stress and use higher glucose and hydroperoxide metabolism for compensation. Therefore, targeting glycolysis and antioxidant pathways could be therapeutic strategies for cancer (9, 36, 37) . On the other hand, mitochondrial O 2 metabolism is critical for the further induction of oxidative stress in cancer upon nutrient starvation such as glucose depletion (8, 37) . Our current findings extend the repertoire of critical cellular processes initiated by nutrient starvation, including the induction of pS473-KAP1 through ROS-/p38MAPK-dependent pathway and the subsequent down-regulation of MFN2, to reduce mitochondrial hyperfusion and OXPHOS in order to ameliorate metabolic oxidative stress.
Although our pharmacological and genetic approaches suggested the involvement of p38 in this process, the specific role of different p38 isoforms in the context of distinct metabolic stress remained obscure, and as such, whether other kinases also mediate oxidative stress-induced pS473-KAP1 signaling needs further study in the future. Presumably, metabolic stress-triggered pS473-KAP1 is a general phenomenon present in both normal and tumor cells. However, since proliferating tumor cells usually exhibit higher oxidative stress and metabolic demands, this signaling pathway could be more prominent in cancer and depend on cells' nutrient dependency.
For example, the fact that MCF7 cells are more glutamine-independent (38) could partially explain why glutamine deprivation-induced pS473-KAP1 was less robust in MCF7 cells ( Figure   1C ). It is likely that primary mammary epithelial cells are relatively resistant to glucose depletion (36) . As shown in Figure 6 , we propose that pS473-KAP1-mediated MFN2 down-regulation is crucial for overcoming nutrient stress during tumor growth.
Upon prolonged metabolic stress, we noted a marked down-regulation of MFN2 that limits the initial hyperfusion response. Although MFN1, another mitofusin, is present, it apparently is unable to compensate for the loss of MFN2. This behavior is consistent with previous observations that disruption of either mitofusin gene leads to severe mitochondrial fragmentation (39) . Clinically, we found lower MFN2 expression correlated with more malignant breast tumors, which is consistent with earlier reports proposing MFN2 as a tumor suppressor (40) (41) (42) . To our knowledge, this is the first study demonstrating that KAP1 can be post-translationally modified upon metabolic stress. Ideally, we would like to observe a gradient of pS473-KAP1 signals, opposite to the MFN2 levels in solid tumors. However, due to the lack of the availability of IHC-quality pS473-KAP1 antibody, our repeated efforts failed to detect any pS473-KAP1 signal using FFPE specimens of either primary patient samples or xenografted tumors. Moreover, whether other post-translational modifications of KAP1 also occur under nutrient deprivation to regulate metabolic stress response deserves more attention. In the current study, we demonstrated that pS473-KAP1 is associated with MFN2 down-regulation upon metabolic stress.
Although the detailed molecular mechanism is unclear, it is possible that KAP1 directly or indirectly regulates MFN2 abundance. Based on our unpublished observations, several microRNAs are up-regulated in S473D-KAP1-re-expressing cells. Among these, potential starvation-induced and MFN2-targeting microRNA is identified and under investigation.
In conclusion, we show that ROS-/p38MAPK-induced pS473-KAP1, following the initial induction of mitochondrial fusion, prevents mitochondrial hyperfusion by down-regulating MFN2, thus promoting the survival of metabolically stressed tumor cells. Our findings not only identify a marker(s) potentially useful for breast cancer stratification but also a mechanistic link for tumor cells to adapt to metabolic stresses during tumor progression and cancer therapy. 202 primary breast cancer samples from Chi-Mei Medical Center were used (also see Table 1 ). The elevated oxidative stress subsequently results in p38MAPK mediated pS473-KAP1 induction.
(C) MFN2 transcript level is down-regulated in primary and
pS473-KAP1 then suppresses mitochondrial hyperfusion via MFN2 down-regulation.
